COSM Cosmos Health
- 0.7490
- +0.0493+7.05%
- 0.7770
- +0.0280+3.74%
Cosmos Health News
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of Its Next Generation AI Drug Repurposing Platform
CHICAGO, IL / ACCESSWIRE / March 21, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
Cosmos Health To Receive Regulatory Approval For C-Scrub Disinfectant In The UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU; No Financial Terms Of Purchase Order Disclosed
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nu
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
CHICAGO, IL / ACCESSWIRE / March 18, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by Over $5 Million
CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders int
Cosmos Health(COSM.US) 10% Shareholder Buys US$49,806 in Common Stocks
$Cosmos Health(COSM.US)$ 10% Shareholder Siokas Grigorios purchased 60,000 shares of Common Stocks on Feb 16, 2024 at an average price of $0.8301 for a total value of $49,806.Source: Announcement What
Cosmos Health CEO Buys Company Shares at Market Price
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
CHICAGO, IL / ACCESSWIRE / February 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative
Lacklustre Performance Is Driving Cosmos Health Inc.'s (NASDAQ:COSM) 34% Price Drop
The Cosmos Health Inc. (NASDAQ:COSM) share price has fared very poorly over the last month, falling by a substantial 34%. The recent drop completes a disastrous twelve months for shareholders, who
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value of their outstanding shares is at $2.7 million. Femasys (NASDAQ:F
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
CHICAGO, IL / ACCESSWIRE / February 1, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
Cosmos Health Files to Sell up to 4.87M Shares of Common Stock for Holder
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
CHICAGO, IL / ACCESSWIRE / January 23, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market With $3.5M Acquisition of 10-Drug Portfolio
CHICAGO, IL / ACCESSWIRE / January 18, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
Cosmos Health Enters Into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
CHICAGO, IL / ACCESSWIRE / December 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative
Cosmos Health CEO to Purchase up to $3M in Common Shares; Stock Rises
Cosmos Health Announces Open Market Stock Purchases By The CEO; Mr Greg Siokas, Intends To Purchase An Aggregate Of Up To $3M In Common Shares Of The Company In The Open Market Through December 31, 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nu
Analysis
Price Target
No Data
